DK0521916T3 - Anvendelse af IL-4 til forøgelse af immunreaktion på infektiøse antigene påvirkninger - Google Patents

Anvendelse af IL-4 til forøgelse af immunreaktion på infektiøse antigene påvirkninger

Info

Publication number
DK0521916T3
DK0521916T3 DK91906129.1T DK91906129T DK0521916T3 DK 0521916 T3 DK0521916 T3 DK 0521916T3 DK 91906129 T DK91906129 T DK 91906129T DK 0521916 T3 DK0521916 T3 DK 0521916T3
Authority
DK
Denmark
Prior art keywords
immune response
agents
influences
inducing
enhance immune
Prior art date
Application number
DK91906129.1T
Other languages
Danish (da)
English (en)
Inventor
Jerome Schwartz
Claude H Nash
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0521916T3 publication Critical patent/DK0521916T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2026IL-4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55522Cytokines; Lymphokines; Interferons
    • A61K2039/55527Interleukins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK91906129.1T 1990-03-21 1991-03-19 Anvendelse af IL-4 til forøgelse af immunreaktion på infektiøse antigene påvirkninger DK0521916T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49683290A 1990-03-21 1990-03-21

Publications (1)

Publication Number Publication Date
DK0521916T3 true DK0521916T3 (da) 1996-03-04

Family

ID=23974340

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91906129.1T DK0521916T3 (da) 1990-03-21 1991-03-19 Anvendelse af IL-4 til forøgelse af immunreaktion på infektiøse antigene påvirkninger

Country Status (19)

Country Link
EP (1) EP0521916B1 (fi)
JP (1) JPH05505799A (fi)
CN (1) CN1055116A (fi)
AT (1) ATE133074T1 (fi)
AU (1) AU656889B2 (fi)
CA (1) CA2078676A1 (fi)
DE (1) DE69116552T2 (fi)
DK (1) DK0521916T3 (fi)
ES (1) ES2082201T3 (fi)
FI (1) FI924215A (fi)
GR (1) GR3019018T3 (fi)
HU (1) HUT63062A (fi)
IE (1) IE72204B1 (fi)
IL (1) IL97600A0 (fi)
MY (1) MY108672A (fi)
OA (1) OA09672A (fi)
PT (1) PT97082B (fi)
WO (1) WO1991014450A1 (fi)
ZA (1) ZA912037B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100191223B1 (ko) * 1989-07-28 1999-06-15 둘락 노먼 씨. 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물
US7449186B1 (en) 1990-08-02 2008-11-11 Fred Hutchinson Cancer Research Center Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
US5827670A (en) * 1990-08-02 1998-10-27 Fred Hutchinson Cancer Research Center Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies
EP0563254B1 (en) * 1990-12-19 1995-11-08 Schering Corporation Use of il-4 to enhance immune response to immunogens in vaccines
CA2099263C (en) * 1991-01-10 1997-03-11 Martin A. Schwarz Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals
GB9124347D0 (en) * 1991-11-15 1992-01-08 Isis Innovation Treatment of macrophages
CA2142862C (en) * 1992-08-19 2000-05-30 Jerome Schwartz Method for inhibiting hiv replication using il-4

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
ES2059453T3 (es) * 1987-08-03 1994-11-16 Tasuku Honjo Un procedimiento para la produccion de interleuquina 4 humana.
JPH0236129A (ja) * 1988-07-22 1990-02-06 Ajinomoto Co Inc ワクチン効果増強剤
EP0454736A4 (en) * 1989-01-20 1993-05-12 The University Of Melbourne Fibrinolysis

Also Published As

Publication number Publication date
IL97600A0 (en) 1992-06-21
PT97082B (pt) 1998-07-31
ATE133074T1 (de) 1996-02-15
IE910921A1 (en) 1991-09-25
AU656889B2 (en) 1995-02-23
ES2082201T3 (es) 1996-03-16
AU7469091A (en) 1991-10-21
OA09672A (en) 1993-05-15
JPH05505799A (ja) 1993-08-26
DE69116552T2 (de) 1996-05-30
CA2078676A1 (en) 1991-09-22
HUT63062A (en) 1993-07-28
CN1055116A (zh) 1991-10-09
EP0521916B1 (en) 1996-01-17
WO1991014450A1 (en) 1991-10-03
PT97082A (pt) 1991-11-29
EP0521916A1 (en) 1993-01-13
GR3019018T3 (en) 1996-05-31
FI924215A0 (fi) 1992-09-21
ZA912037B (en) 1992-03-25
DE69116552D1 (de) 1996-02-29
IE72204B1 (en) 1997-04-09
MY108672A (en) 1996-10-31
FI924215A (fi) 1992-09-21

Similar Documents

Publication Publication Date Title
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
ZA936629B (en) Potentiation of immunogenic response
DE69130071D1 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
DE60040740D1 (de) VERWENDUNG OF INTERLEUkIN-1 MUTEIN ALS IMPFSTOFFADJUVANS
ITMI913092A1 (it) Vaccino di poxvirus ricombinante del virus del morbillo
DK0521916T3 (da) Anvendelse af IL-4 til forøgelse af immunreaktion på infektiøse antigene påvirkninger
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
DE69129459T2 (de) Immunosuppressive zusammensetzungen
DK0563254T3 (da) Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner
ATE67783T1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
ATE229981T1 (de) Glykolisierte cytokine
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
DE69706657T2 (de) Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen
DE69123252T2 (de) Kreuzreaktive immunisierung gegen influenza
RU93043610A (ru) Фармацевтическая композиция для усиления первичной иммуно-реакции у млекопитающих, способ усиления первичной иммуно-реакции и применение интерлейкина-4 для усиления первичной иммуно-реакции у млекопитающих, набор лекарственных средств
ITRM910038A1 (it) Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale.